Colecalciferol

• A PHASE III OPEN LABEL STUDY CONTROLLED BY VITAMIN D3 SUPPLEMENTATION AND THE DIFFERENCES BETWEEN YOUNG ADULTS AND SENIOR POPULATION Not authorised
  2024-511889-36-01 Phase III 1 country Fakultni Nemocnice Plzen
• Vitamin D as add-on treatment option of pneumonia and sepsis in elderly subjects (TreatViD) Pending
  2024-515978-27-00 Phase III/IV 1 country Azienda Ospedaliero-Universitaria Maggiore Della Carita
• DonneDvit : Assessing the Impact of a Mode of Vitamin D Supplementation on the Incidence of Hypercalciuria in Subjets Aged From 2 to 18 Year… Pending
  2024-518219-20-00 Phase IV 1 country Centre Hospitalier Universitaire De Montpellier
• Role in GVHD prophylaxis of Vitamin D in patients undergoing allogeneic transplantation of stem cells. Phase II Pilot Study Pending
  2024-518738-97-00 Phase II 1 country Azienda Ospedaliero Universitaria Pisana
• EFFECTIVENESS OF SUPPLEMENTATION WITH VITAMIN D IN PATIENTS WITH DEPRESSIVE DISORDER OR BIPOLAR DISORDER: A RANDOMIZED CONTROLLED CLINICAL T… Pending
  2025-520778-20-00 Phase III/IV 1 country Azienda Ospedaliera Universitaria Senese
• Clinical study to investigate the Efficacy and Safety of Encaleret Compared to Standard of Care treatment in patients with Autosomal Dominan… Recruiting
  2022-501398-38-00 Phase III 6 countries Calcilytix Therapeutics Inc.
• Otevřená studie fáze III kontrolovaná suplementací vitaminu D3 a rozdíly mezi mladými dospělými a seniory Recruiting
  2024-519747-15-00 Phase III 1 country Fakultni Nemocnice Plzen
• The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosi… Recruiting
  2024-517886-18-00 Phase III 1 country Fakultni Nemocnice V Motole
• Beneficial effects of vitamin D combined with oral iron supplementation in patients with chronic heart failure and iron deficiency (VICTORID… Recruiting
  2024-519878-39-00 Phase IV 1 country Universita Degli Studi Di Padova
• OBEVIDOS “Treatment of vitamin D deficit in obese children and adolescents: an open label randomized controlled study comparing the efficacy… Recruiting
  2023-507089-18-00 Phase III 1 country Hospices Civils De Lyon
• REQUIRED DOSE OF CHOLECALCIFEROL IN THE MANAGEMENT OF VITAMIN D DEFICIENCY AND INSUFFICIENCY IN POSTMENOPAUSAL WOMEN Recruiting
  2023-504664-42-02 Phase III 1 country Clinica Palacios Madrid S.L.
• Efficacy comparison of two doses of vitamin D3 in critically ill patients undergoing continuous renal replacement therapy - NephroD Recruiting
  2024-510834-42-00 Phase IV 1 country Uniwersytecki Szpital Kliniczny W Opolu
• Vitamin D Supplementation to increase free testosteron in Type 2 Diabetes Mellitus men: a Placebo-controlled Randomized Clinical Trial Recruiting
  2024-514834-19-00 Phase II 1 country UZ Brussel
• Effect of high-dose vitamin D on 28-day mortality in adult critically ill patients with severe vitamin D deficiency Recruiting
  2024-514556-32-00 Phase III 2 countries Medical University Of Graz
• MULTICENTER, RANDOMIZED, BLIND AND CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY IN THE CORRECTION OF DEFICIT IN SUBJECTS WI… Ended
  2024-514528-17-00 Phase IV 1 country Itf Research Pharma S.L.
• DOVIPA, a phase II study evaluating efficacy and safety of DOstarlimab and oral VItamin D3 with folinic acid, 5FU, Irinotecan plus oxalipalt… Ended
  2023-510004-49-00 Phase II 1 country Hospital Foch
• Effect of Vitamin D supplementation in participants with periodontitis and vitamin D deficiency. Ended
  2023-503671-16-00 Phase IV 1 country Laboratoires S.M.B.
• Study of total post-thyroidectomy hypocalcemia after preoperative cholecalciferol supplementation Ended
  2024-516793-30-00 Phase III 1 country Hopital NOVO
• Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis Ended
  2023-503790-37-00 Phase III 6 countries Curateq Biologics Private Limited
• A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents … Ended
  2024-513304-33-00 Phase III 8 countries Diamyd Medical AB
• Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid Ended
  2024-519705-36-00 Phase IV 4 countries NHS Lothian; University Of Edinburgh

Showing 1–21 of 21 trials